Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
about
Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidenceChlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaChlorproguanil-dapsone for treating uncomplicated malariaFosmidomycin plus clindamycin for treatment of pediatric patients aged 1 to 14 years with Plasmodium falciparum malariaG6PD deficiency: a classic example of pharmacogenetics with on-going clinical implicationsGlucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malariaPyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot studyOpen-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malariaAn open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malariaIntermittent preventive treatment in infants for the prevention of malaria in rural Western kenya: a randomized, double-blind placebo-controlled trialHigh risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiencyFitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparumGlucose-6-Phosphate Dehydrogenase Deficiency and Haemoglobin Drop after Sulphadoxine-Pyrimethamine Use for Intermittent Preventive Treatment of Malaria during Pregnancy in Ghana - A Cohort StudyChanging Malaria Prevalence on the Kenyan Coast since 1974: Climate, Drugs and Vector ControlModelling the epidemiological impact of intermittent preventive treatment against malaria in infants.Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon.In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individualsMutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, MalawiFighting malaria at the crossroads.Pharmacovigilance of antimalarial treatment in Africa: is it possible?Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the GambiaHigh prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese childrenFrequency of glucose-6-phosphate dehydrogenase deficiency in malaria patients from six African countries enrolled in two randomized anti-malarial clinical trialsIntermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malariaPopulation pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in InfantsPharmGKB summary: very important pharmacogene information for G6PD.Drug-resistant malariaResistance to sulphadrug-based antifolate therapy in malaria: are we looking in the right place?CYP2C8 and antimalaria drug efficacy.Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon.Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups.Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy.Dihydrofolate reductase inhibitors: developments in antiparasitic chemotherapy.Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants?Medical research at the Albert Schweitzer Hospital.The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.Winning the drugs war.
P2860
Q21032450-011638E9-E5CB-4348-A412-01035614CE9AQ21143739-CDE64F8C-F8B9-430B-AB52-167B1011EFF1Q24245853-B2635C27-8C60-439A-B674-2E75D1FF8AD9Q24680404-2CABAD06-6495-45A9-BA31-276AF0C8D940Q27005605-C992D8F4-40C3-41AF-8DAB-FCA63D6614B4Q28265711-98485BB9-119D-46FA-B0B1-0ACC34A11E9DQ28275227-D12A6FC0-B9BF-4A68-81FA-553B199565D2Q28472247-2CC40D37-578A-4A69-9429-90382587824DQ28473004-569187BF-8D37-4E7D-A8F7-1DFA47C8E55FQ28473566-95EA8909-3C75-4962-B2B3-4110A60F8B05Q28474365-ACD26ED0-0BA2-42E8-B06B-DCD972D11D38Q28478215-CEE837DB-DDD8-4884-AC00-3488EDB0EA6CQ28547654-56225700-8CCD-4518-B4C3-EB531DCCAF74Q28548617-037A5A64-320A-4652-BB79-76F7022FE50CQ33351939-FFDCA61D-3975-471F-B56C-0F6318EB1437Q33711903-BBCD1278-A743-43D2-96B5-1ED585CEDF8EQ33826283-29DD5CD6-CF64-42A4-BB67-13072D4230B9Q33935361-530CA4AF-163D-4F63-B93B-EBAE388ED479Q34166255-3343A07A-9850-4A36-AF84-F09A5F3B65EFQ34872414-95D8FB3F-A1EF-418B-9405-FDA0564DBEECQ35031434-4CB1D5F4-5E35-4ABD-A924-038AEE767C45Q35038632-1E198CB9-2254-4E05-825C-2224CF4E2001Q35283214-CDDF5FBB-A725-4EC4-81D3-00EDB6B5829EQ35652102-FE111344-4689-45CD-9D8E-169092F90596Q35759028-B4ED2933-9D81-4039-9DDD-859EEA254ABDQ35827434-2AD26403-8A34-4101-A358-905F24DD5286Q35842358-8CA84CC2-0823-4139-B56A-BBEDF24526A7Q35850290-1F24905A-7A28-446E-9EAF-7CABA38AFB49Q36055205-9C658E0E-2776-438A-B10F-4CD8D53ACA19Q36248426-7791AB65-7720-4A9B-938D-144B0EC90F5CQ36505818-CC3466C7-EC8C-4B0D-A3C3-6A0E3422DB3DQ36730638-34ABC1B9-06C4-4155-90B8-96F960E21F5FQ36981978-B1ECE34A-3090-4AEA-A15D-5B17E82FD60AQ37315138-834FDF2F-2748-4AEC-A612-9812A07B5EE9Q37735182-D0182E24-41A2-4AE2-8814-40CC84F8C426Q37765574-028ACC70-3BEB-4881-8A9F-FCDA662DB636Q39029573-4A9408B0-4E08-4CF2-AB9E-8ED537B174A6Q39096704-9A2644DE-A4D2-49E5-BCE5-07C3B67F1DD4Q39351643-AEAF168D-EC1D-460A-9762-FA7697B4B598Q39397998-15AB6C86-1F1C-4C5E-B1D9-CFDC98BC7C26
P2860
Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Comparison of chlorproguanil-d ...... d randomised controlled trial.
@en
type
label
Comparison of chlorproguanil-d ...... d randomised controlled trial.
@en
prefLabel
Comparison of chlorproguanil-d ...... d randomised controlled trial.
@en
P2093
P921
P1433
P1476
Comparison of chlorproguanil-d ...... d randomised controlled trial.
@en
P2093
A Alloueche
A M J Oduola
C Mkandala
C O Falade
F A Fehintola
J G Kublin
L Robertson
M A Missinou
P304
P356
10.1016/S0140-6736(04)16350-2
P407
P577
2004-06-01T00:00:00Z